SynthesisThe oncologist2012
Critical appraisal of translational research models for suitability in performance assessment of cancer centers.
Synthesis in The oncologist, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Assessing excellence in translational cancer research: a consensus based framework.Journal of translational medicine · 2013Pooled it
- Features and applications of Ehrlich tumor model in cancer studies: a literature review.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2023Review
- Influence of Information Sources on Chinese Parents Regarding COVID-19 Vaccination for Children: An Online Survey.International journal of environmental research and public health · 2022Article
- Translation research in occupational health and safety settings: Common ground and future directions.Journal of safety research · 2020Article
- Toward a science of translational science.Journal of clinical and translational science · 2017Article
- Broadening measures of success: results of a behavioral health translational research training program.Implementation science : IS · 2017Article
- Quality assessments for cancer centers in the European Union.BMC health services research · 2016Article
- Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.Molecular oncology · 2016Review
- Translating research into prevention of high-risk behaviors in the presence of complex systems: definitions and systems frameworks.Translational behavioral medicine · 2016Article
- Quantitative evaluation of translational medicine based on scientometric analysis and information extraction.Clinical and translational science · 2014Article
- Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin.Journal of translational medicine · 2014Article
- Modeling the dissemination and uptake of clinical trials results.Research Evaluation · 2013Article
- Framework for Creating Successful Multidisciplinary Translational Research Teams.Indian journal of community medicine : official publication of Indian Association of Preventive & Social MedicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranslational research is a complex cumulative process that takes time. However, the operating environment for cancer centers engaged in translational research is now financially insecure. Centers are challenged to improve results and reduce time from discovery to practice innovations. Performance assessment can identify improvement areas that will help reduce translational delays. Currently, no standard method exists to identify models for use in performance assessment. This study aimed to critically appraise translational research models for suitability in performance assessment of cancer centers.
methodsWe conducted a systematic review to identify models and developed a set of criteria based on scientometrics, complex adaptive systems, research and development processes, and strategic evaluation. Models were assessed for linkage between research and care components, new knowledge, systems integration, performance assessment, and review of other models.
resultsTwelve models were identified; six described phases/components for translational research in different blocks (T models) and six described the process of translational research (process models). Both models view translational research as an accumulation of new knowledge. However, process models more clearly address systems integration, link research and care components, and were developed for evaluating and improving the performance of translational research. T models are more likely to review other models.
conclusionProcess models seem to be more suitable for performance assessment of cancer centers than T models. The most suitable process models (the Process Marker Model and Lean and Six Sigma applications) must be thoroughly tested in practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.